1. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells
   Xiangyu Chen et al, 2017, Immunol Res CrossRef
2. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice
   Liping Chen et al, 2020, Front. Immunol. CrossRef
3. Increase in Epithelial Permeability and Cell Metabolism by High Mobility Group Box 1, Inflammatory Cytokines and TPEN in Caco-2 Cells as a Novel Model of Inflammatory Bowel Disease
   Maki Miyakawa et al, 2020, IJMS CrossRef
4. Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?
   Armando Rojas et al, 2021, WJG CrossRef
5. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition
   Toshihide Ueda et al, 2015, Digestion CrossRef